An immunohistochemical study of basal cell carcinoma and trichoepithelioma.
暂无分享,去创建一个
[1] J. Ring,et al. Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma. , 1998, The American Journal of dermatopathology.
[2] M. Wick,et al. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens , 1998, Journal of cutaneous pathology.
[3] T. Aramendi,et al. Cutaneous lymphadenoma: an adnexal neoplasm with intralobular activated lymphoid cells. , 1998, The American Journal of dermatopathology.
[4] W. Hartschuh,et al. Merkel cells are absent in basal cell carcinomas but frequently found in trichoblastomas. An immunohistochemical study , 1997, Journal of cutaneous pathology.
[5] J. Val-Bernal,et al. Perianal basal cell carcinoma: a comparative histologic, immunohistochemical, and flow cytometric study with basaloid carcinoma of the anus. , 1996, The American Journal of dermatopathology.
[6] B. Smoller,et al. Use of CD34 in assessing the relationship between stroma and tumor in desmoplastic keratinocytic neoplasms , 1995, Journal of cutaneous pathology.
[7] M. Rijn,et al. bcl-2 expression in primary malignancies of the skin. , 1995, Archives of dermatology.
[8] R. Brown,et al. Utility of microwave-citrate antigen retrieval in diagnostic immunohistochemistry. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[9] D. Bryant,et al. Immunostaining for CD34 to determine trichoepithelioma. , 1995, Archives of dermatology.
[10] R. Warnke,et al. bcl‐2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas , 1994, The British journal of dermatology.
[11] B. Smoller,et al. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma. , 1994, Archives of dermatology.
[12] I. Campbell,et al. Keratin expression in normal skin and epidermal neoplasms demonstrated by a panel of monoclonal antibodies , 1992, Journal of cutaneous pathology.
[13] M. Heng,et al. Expression of Ulex europaeus Agglutinin I Lectin‐Binding Sites in Squamous Cell Carcinomas and Their Absence in Basal Cell Carcinomas: Indicator of Tumor Type and Differentiation , 1992, The American Journal of dermatopathology.
[14] A. Ackerman,et al. Infundibulocystic basal cell carcinoma: a newly described variant. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[15] S. Pileri,et al. BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. , 1989, Blood.
[16] F. Stirpe,et al. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. , 1995, Blood.